Literature DB >> 17691835

The spectrophysics of warfarin: implications for protein binding.

Björn C G Karlsson1, Annika M Rosengren, Per Ola Andersson, Ian A Nicholls.   

Abstract

The photophysical behavior of the isomers of the anticoagulant drug warfarin in various solvents and solvent mixtures was investigated using absorption, 1H NMR, and steady-state and time-resolved fluorescence spectroscopies in conjunction with B3LYP-based theoretical treatments. Complex absorption patterns were observed, indicative of the presence of different isomers of warfarin in the various solvents studied. In alkaline aqueous solution, the deprotonated open side form of warfarin is highly dominant and only one S0-->S1 singlet transition could be observed in the absorption spectrum centered at 320 nm. These observations were supported by theoretical density functional calculations (B3LYP) in which the geometries of nine isomers of warfarin were optimized and their respective eight lowest singlet and three lowest triplet excitation energy levels were predicted. Examination of the fluorescence excitation and emission spectra of the isomers in nonpolar and polar organic solvents showed the presence of the deprotonated open side chain form of warfarin in 2-propanol, ethanol, and acetonitrile. Time-resolved fluorescence experiments revealed a short decay time constant, tau1, in all solvents studied while in more polar environments a second longer one, tau2, was evident varying between 0.5 and 1.6 ns depending on solvent polarity. The variation of number and length of fluorescence lifetimes as a function of solvent environment has provided a tool for examining warfarin protein binding. Studies on the binding of warfarin to human serum albumin (HSA) have been undertaken, and different modes of binding were observed which are indicative of binding to the anion-selective Sudlow I and, second, a lower affinity mode of interaction.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17691835     DOI: 10.1021/jp072505i

Source DB:  PubMed          Journal:  J Phys Chem B        ISSN: 1520-5207            Impact factor:   2.991


  6 in total

1.  Monitoring the distribution of warfarin in blood plasma.

Authors:  Annika M Rosengren; Björn C G Karlsson; Ian A Nicholls
Journal:  ACS Med Chem Lett       Date:  2012-06-20       Impact factor: 4.345

2.  Binding of puerarin to human serum albumin: a spectroscopic analysis and molecular docking.

Authors:  Yang He; Yiwei Wang; Lifei Tang; Hui Liu; Wei Chen; Zhongliang Zheng; Guolin Zou
Journal:  J Fluoresc       Date:  2007-12-06       Impact factor: 2.217

3.  Interactive multiple binding of oleic acid, warfarin and ibuprofen with human serum albumin revealed by thermal and fluorescence studies.

Authors:  Rita Guzzi; Rosa Bartucci
Journal:  Eur Biophys J       Date:  2022-01-20       Impact factor: 1.733

4.  Enumeration of ring-chain tautomers based on SMIRKS rules.

Authors:  Laura Guasch; Markus Sitzmann; Marc C Nicklaus
Journal:  J Chem Inf Model       Date:  2014-09-09       Impact factor: 4.956

5.  Sequestration Effect on the Open-Cyclic Switchable Property of Warfarin Induced by Cyclodextrin: Time-Resolved Fluorescence Study.

Authors:  Naji Al-Dubaili; Na'il Saleh
Journal:  Molecules       Date:  2017-08-11       Impact factor: 4.411

6.  Consequences of morphology on molecularly imprinted polymer-ligand recognition.

Authors:  Annika M Rosengren; Björn C G Karlsson; Ian A Nicholls
Journal:  Int J Mol Sci       Date:  2013-01-09       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.